Dose response of ACE inhibitors: implications of the SECURE trial

about

Peripheral arterial disease and cognitive function.Treatment optimization of angiotensin converting enzyme inhibitors and associated factors in Ayder Comprehensive Specialized Hospital: a cross-sectional study.

P2860

Q37368720-4896FE68-5131-49CB-88C0-4B6CCA5DD2F7 Q55027420-AA2B8079-4490-4FFE-931B-B8709EE857A0

P2860

Dose response of ACE inhibitors: implications of the SECURE trial

Item

http://www.wikidata.org/entity/Q24793271

description

2001 nî lūn-bûn

@nan

2001 թուականին հրատարակուած գիտական յօդուած

@hyw

2001 թվականին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Dose response of ACE inhibitors: implications of the SECURE trial

@ast

Dose response of ACE inhibitors: implications of the SECURE trial

@en

Dose response of ACE inhibitors: implications of the SECURE trial

@nl

type

Item

label

Dose response of ACE inhibitors: implications of the SECURE trial

@ast

Dose response of ACE inhibitors: implications of the SECURE trial

@en

Dose response of ACE inhibitors: implications of the SECURE trial

@nl

prefLabel

Dose response of ACE inhibitors: implications of the SECURE trial

@ast

Dose response of ACE inhibitors: implications of the SECURE trial

@en

Dose response of ACE inhibitors: implications of the SECURE trial

@nl

P1476

Dose response of ACE inhibitors: implications of the SECURE trial

@en

P2093

Eva Lonn

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure.

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease.

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.

P2888

cvm-2-4-155

P304

155-159

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CVM-2-4-155

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11552022

http://www.w3.org/2001/XMLSchema#string

P6179

1013269318

http://www.w3.org/2001/XMLSchema#string

P698

11806789

http://www.w3.org/2001/XMLSchema#string

P932

59639

http://www.w3.org/2001/XMLSchema#string

Dose response of ACE inhibitors: implications of the SECURE trial

about

P2860

P2860

Dose response of ACE inhibitors: implications of the SECURE trial

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P6179

P698

P932